Introduction
The precision medicine revolution in diabetes care is predicated on the accurate interpretation of genetic variants. Maturity-Onset Diabetes of the Young (MODY) represents a heterogeneous group of monogenic diabetes forms where a molecular diagnosis significantly alters clinical management—ranging from the discontinuation of insulin in HNF1A-MODY to the avoidance of unnecessary treatment in GCK-MODY. However, a persistent challenge in clinical genetics is the interpretation of loss-of-function (LOF) variants, particularly those occurring in the final exon or the penultimate exon’s 3-prime end, which may escape the cellular surveillance mechanism known as nonsense-mediated decay (NMD). A landmark study by Laver et al. (2026) provides a systematic framework for understanding these variants across ten MODY genes, uncovering a novel genetic cause for the disease within the insulin (INS) gene itself.
1. Pathogenicity of LOF variants in MODY is highly gene-specific and dictated by whether the transcript triggers or escapes NMD.2. NMD-escape variants in the INS gene are established as a novel cause of MODY, distinct from neonatal diabetes.3. INS-MODY caused by NMD-escape variants presents approximately a decade later than missense-driven INS-MODY.4. Protein modeling reveals that these novel INS variants lead to aberrant proinsulin molecules with unpaired cysteines, causing chronic beta-cell stress.
